Article
A risk stratification model based on four novel biomarkers predicts prognosis for patients with renal cell carcinoma.
2020-10-19
Abstract excerpt
<title>Abstract</title> <p><bold>Background</bold>: Accurate prediction of the prognosis of RCC using a single biomarker is challenging due to the genetic heterogeneity of the disease. However, it is essential to develop an accurate system to allow better patient selection for optimal treatment strategies. ARL4C, ECT2, SOD2 and STEAP3 are novel molecular biomarkers identified in earlier studies as survival-relate...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 642048e6-39f5-51f4-a482-d609a551e60d
- DOI
- 10.21203/rs.3.rs-47739/v2
